QT
NXTC icon

Quantbot Technologies’s NextCure NXTC Stock Holding History

Quantbot Technologies’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-175
Closed -$9K – 1937
2022
Q2 		$9K Hold
175
– – ﹤0.01% 1541
2022
Q1 		$10K Sell
175
-150
-46% -$9.39K ﹤0.01% 1465
2021
Q4 		$23K Buy
+325
New +$27.2K ﹤0.01% 1202

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Quantbot Technologies's NXTC Position: Q3 2022 in Review

Quantbot Technologies sold out of NextCure (NXTC) in Q3 2022, closing a stake of 175 shares — an estimated $9K sold.

Quantbot Technologies first reported a position in NXTC in Q4 2021 and held it in 3 quarters. The position peaked at $23K in Q4 2021. 52 funds tracked by Wall St. Rank hold NXTC as of Q3 2022.

  • Quantbot Technologies reported no remaining NextCure position as of Q3 2022 after selling out during the quarter.
  • Quantbot Technologies sold 175 NextCure shares in Q3 2022, an estimated $9K.
  • Quantbot Technologies first reported a position in NextCure in Q4 2021 and held it in 3 quarters.
  • Quantbot Technologies's NextCure position peaked at $23K in Q4 2021.
  • 52 funds tracked by Wall St. Rank held NextCure as of Q3 2022.

Based on Quantbot Technologies's 13F filing for Q3 2022, filed 7 Nov 2022.